Cargando…
CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer
Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breast cancer and inhibits breast cancer cell proliferation upon overexpression. However, the mechanism by which CLDN6 inhibits breast cancer proliferation is unclear. Here, we investigated this issue and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745066/ https://www.ncbi.nlm.nih.gov/pubmed/35008557 http://dx.doi.org/10.3390/ijms23010129 |
_version_ | 1784630255614427136 |
---|---|
author | Qu, Huinan Qi, Da Wang, Xinqi Dong, Yuan Jin, Qiu Wei, Junyuan Quan, Chengshi |
author_facet | Qu, Huinan Qi, Da Wang, Xinqi Dong, Yuan Jin, Qiu Wei, Junyuan Quan, Chengshi |
author_sort | Qu, Huinan |
collection | PubMed |
description | Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breast cancer and inhibits breast cancer cell proliferation upon overexpression. However, the mechanism by which CLDN6 inhibits breast cancer proliferation is unclear. Here, we investigated this issue and elucidated the molecular mechanisms by which CLDN6 inhibits breast cancer proliferation. First, we verified that CLDN6 was lowly expressed in breast cancer tissues and that patients with lower CLDN6 expression had a worse prognosis. Next, we confirmed that CLDN6 inhibited breast cancer proliferation through in vitro and in vivo experiments. As for the mechanism, we found that CLDN6 inhibited c–MYC–mediated aerobic glycolysis based on a metabolomic analysis of CLDN6 affecting cellular lactate levels. CLDN6 interacted with a transcriptional co–activator with PDZ-binding motif (TAZ) and reduced the level of TAZ, thereby suppressing c–MYC transcription, which led to a reduction in glucose uptake and lactate production. Considered together, our results suggested that CLDN6 suppressed c–MYC–mediated aerobic glycolysis to inhibit the proliferation of breast cancer by TAZ, which indicated that CLDN6 acted as a novel regulator of aerobic glycolysis and provided a theoretical basis for CLDN6 as a biomarker of progression in breast cancer. |
format | Online Article Text |
id | pubmed-8745066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87450662022-01-11 CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer Qu, Huinan Qi, Da Wang, Xinqi Dong, Yuan Jin, Qiu Wei, Junyuan Quan, Chengshi Int J Mol Sci Article Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breast cancer and inhibits breast cancer cell proliferation upon overexpression. However, the mechanism by which CLDN6 inhibits breast cancer proliferation is unclear. Here, we investigated this issue and elucidated the molecular mechanisms by which CLDN6 inhibits breast cancer proliferation. First, we verified that CLDN6 was lowly expressed in breast cancer tissues and that patients with lower CLDN6 expression had a worse prognosis. Next, we confirmed that CLDN6 inhibited breast cancer proliferation through in vitro and in vivo experiments. As for the mechanism, we found that CLDN6 inhibited c–MYC–mediated aerobic glycolysis based on a metabolomic analysis of CLDN6 affecting cellular lactate levels. CLDN6 interacted with a transcriptional co–activator with PDZ-binding motif (TAZ) and reduced the level of TAZ, thereby suppressing c–MYC transcription, which led to a reduction in glucose uptake and lactate production. Considered together, our results suggested that CLDN6 suppressed c–MYC–mediated aerobic glycolysis to inhibit the proliferation of breast cancer by TAZ, which indicated that CLDN6 acted as a novel regulator of aerobic glycolysis and provided a theoretical basis for CLDN6 as a biomarker of progression in breast cancer. MDPI 2021-12-23 /pmc/articles/PMC8745066/ /pubmed/35008557 http://dx.doi.org/10.3390/ijms23010129 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Qu, Huinan Qi, Da Wang, Xinqi Dong, Yuan Jin, Qiu Wei, Junyuan Quan, Chengshi CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title | CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title_full | CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title_fullStr | CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title_full_unstemmed | CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title_short | CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer |
title_sort | cldn6 suppresses c–myc–mediated aerobic glycolysis to inhibit proliferation by taz in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745066/ https://www.ncbi.nlm.nih.gov/pubmed/35008557 http://dx.doi.org/10.3390/ijms23010129 |
work_keys_str_mv | AT quhuinan cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT qida cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT wangxinqi cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT dongyuan cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT jinqiu cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT weijunyuan cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer AT quanchengshi cldn6suppressescmycmediatedaerobicglycolysistoinhibitproliferationbytazinbreastcancer |